Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00715650 · ClinicalTrials.gov registry record · Phase 2
Benefits Counseling to Preserve Function Among Disability Applicants
A Phase 2 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 92
- Enrollment target
NCT00715650: Completed Phase 2 study, sponsored by VA Office of Research and Development.
NCT00715650 is a Phase 2 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 92 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (31% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00715650, a Phase 2 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 92 participants
- Enrollment target
Study Summary
This study will address the problem that claimants with psychiatric disabilities who apply for and receive disability benefits go on to work less than those whose claims are denied.
Primary Outcome
Number of days in the past 28 spent engaged in any kind of work or related activity. Measured using a timeline follow-back calendar.
Interventions
- BEHAVIORAL Benefits Counseling
- BEHAVIORAL VA Orientation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2008-12 |
| Est. Completion | 2015-12 |
| Phase | Phase 2 |
What the finished NCT00715650 record still lists
NCT00715650 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (31% lower).
The record links to 0 conditions, and to 2 interventions - of which Benefits Counseling is the first listed.
NCT00715650 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00715650 about?
NCT00715650 is a clinical study titled "Benefits Counseling to Preserve Function Among Disability Applicants". This study will address the problem that claimants with psychiatric disabilities who apply for and receive disability benefits go on to work less than those whose claims are denied.
What is the current status of trial NCT00715650?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 92 participants. The study started on 2008-12. Estimated completion is 2015-12.
What interventions are being tested in trial NCT00715650?
The interventions under investigation include: Benefits Counseling (BEHAVIORAL), VA Orientation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00715650?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00715650's enrollment target sits among peer trials
92 767th of 2000 higher than 1,230 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia